Clinical Trials Browser

Phase 1 × Breast Neoplasms × Gene Expression Profiling × Clear all

NCT00544804 2014-07-02

Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2

Phase 1 Completed

Breast Neoplasms, Neoplasm Metastasis